...
首页> 外文期刊>Radiology >Risk of intravenous contrast material-mediated acute kidney injury: A propensity score-matched study stratified by baseline-estimated glomerular filtration rate
【24h】

Risk of intravenous contrast material-mediated acute kidney injury: A propensity score-matched study stratified by baseline-estimated glomerular filtration rate

机译:静脉造影剂介导的急性肾损伤的风险:一项倾向评分匹配的研究,以基线估计的肾小球滤过率分层

获取原文
获取原文并翻译 | 示例

摘要

Purpose: To determine the effect of baseline estimated glomerular filtration rate (eGFR) on the causal association between intravenous iodinated contrast material exposure and subsequent development of acute kidney injury (AKI) in propensity score-matched groups of patients who underwent contrast material-enhanced or unenhanced computed tomography (CT). Materials and Methods: This retrospective study was HIPAA compliant and institutional review board approved. All patients who underwent contrast-enhanced (contrast material group) or unenhanced (non-contrast material group) CT between 2000 and 2010 were identified and stratified according to baseline eGFR by using Kidney Disease Outcomes Quality Initiative cutoffs for chronic kidney disease into subgroups with eGFR of 90 or greater, 60-89, 30-59, and less than 30 mL/min/1.73 m 2. Propensity score generation and 1:1 matching of patients were performed in each eGFR subgroup. Incidence of AKI (serum creatinine [SCr] increase of ≥0.5 mg/dL [≥44.2 μmol/L] above baseline) was compared in the matched subgroups by using the Fisher exact test. Results: A total of 12 508 propensity score-matched patients with contrast-enhanced and unenhanced scans met all inclusion criteria. In this predominantly inpatient cohort, the incidence of AKI significantly increased with decreasing baseline eGFR (P .0001). However, this incidence was not significantly different between contrast material and non-contrast material groups in any eGFR subgroup; for the subgroup with eGFR of 90 or greater (n = 1642), odds ratio (OR) was 0.91 (95% confidence interval [CI]: 0.38, 2.15), P = .82; for the subgroup with eGFR of 60-89 (n = 3870), OR was 1.03 (95% CI: 0.66, 1.60), P = .99; for the subgroup with eGFR of 30-59 (n = 5510), OR was 0.94 (95% CI: 0.76, 1.18), P = .65; and for the subgroup with eGFR of less than 30 mL/min/1.73 m2 (n = 1486), OR was 0.97 (95% CI: 0.72, 1.30), P = .89. Conclusion: Diminished eGFR is associated with an increased risk of SCr-defined AKI following CT examinations. However, the risk of AKI is independent of contrast material exposure, even in patients with eGFR of less than 30 mL/min/1.73 m2.
机译:目的:为了确定基线评估的肾小球滤过率(eGFR)对静脉造影剂碘暴露与倾向评分匹配组或接受造影剂增强或造影剂治疗的患者中急性肾损伤(AKI)随后发展之间因果关系的影响增强型计算机断层扫描(CT)。材料和方法:这项回顾性研究符合HIPAA标准,并获得了机构审查委员会的批准。根据基线eGFR,通过使用肾脏疾病结果质量倡议将慢性肾脏疾病的临界值划分为eGFR的亚组,对所有在2000年至2010年间接受了CT增强对比(对比材料组)或未增强CT(非对比材料组)的患者进行分类。 90或更大,60-89、30-59和小于30 mL / min / 1.73 m2。在每个eGFR亚组中进行了倾向得分的产生和患者的1:1匹配。使用Fisher精确检验,在匹配的亚组中比较了AKI的发生率(血清肌酐[SCr]增加至基线以上≥0.5mg / dL [≥44.2μmol/ L])。结果:共有12 508名倾向评分匹配的患者进行了对比增强和未增强扫描,均符合所有纳入标准。在这个以住院为主的队列中,随着基线eGFR的降低,AKI的发生率显着增加(P <.0001)。但是,在任何eGFR子组中,对比材料组和非对比材料组之间的发生率没有显着差异。对于eGFR为90或更高(n = 1642)的亚组,优势比(OR)为0.91(95%置信区间[CI]:0.38,2.15),P = 0.82;对于eGFR为60-89(n = 3870)的亚组,OR为1.03(95%CI:0.66,1.60),P = .99;对于eGFR为30-59(n = 5510)的亚组,OR为0.94(95%CI:0.76,1.18),P = 0.65;对于eGFR低于30 mL / min / 1.73 m2(n = 1486)的亚组,OR为0.97(95%CI:0.72,1.30),P = 0.89。结论:eGFR降低与CT检查后SCr定义的AKI风险增加有关。但是,即使eGFR低于30 mL / min / 1.73 m2的患者,AKI的风险也与造影剂的暴露无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号